Article Replacement Under Process

“Improving Rituximab Infusion Waiting Time for Lymphoma Patients (CD20 positive) at Johns Hopkins Aramco Healthcare: A Clinical Practice Quality Improvement Initiative”

Article has been withdrawn by Corresponding and Co - Authours. Approved by InnovationInfo Publishing

Corresponding author: Dr. Huda Alsayed Ahmed, PhD, CHQO,Healthcare Quality Specialist, Quality & Patient Safety Department,Johns Hopkins Aramco Healthcare, Saudi Arabia-Dhahran. Tel: +00966504803854; Email: huda.alsayedahmed(at)jhah.com